While the mechanism underlying the aberrant overexpression of TRPM7 in malignant neoplasia has yet to be determined, the existing data support the exploration of its clinical significance in pancreatic adenocarcinoma and the other malignancies. The gene discussed is TRPM7; the disease is pancreatic adenocarcinoma.